WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017055909) COMBINATION OF GLYCOSAMINOGLYCANS AND AN ANTACID AGENT AND COMPOSITIONS THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2017/055909    International Application No.:    PCT/IB2016/001423
Publication Date: 06.04.2017 International Filing Date: 30.09.2016
IPC:
A61K 31/728 (2006.01), A61K 33/06 (2006.01), A61K 31/737 (2006.01), A61K 9/06 (2006.01), A61K 9/08 (2006.01), A61K 9/10 (2006.01), A61P 1/04 (2006.01), A61K 45/06 (2006.01)
Applicants: APHARM S.R.L. [IT/IT]; Via Roma, 26 28041 Arona (NO) (IT)
Inventors: PIZZONI, Angelo; (IT).
PIZZONI, Paolo; (IT)
Agent: SANTORO, Tiziana; Marietti, Gislon e Trupiano S.r.l. Via Larga, 16 20122 Milano (IT)
Priority Data:
UB2015A004158 01.10.2015 IT
UA2016A002869 26.04.2016 IT
Title (EN) COMBINATION OF GLYCOSAMINOGLYCANS AND AN ANTACID AGENT AND COMPOSITIONS THEREOF
(FR) ASSOCIATION DE GLYCOSAMINOGLYCANES ET D'UN AGENT ANTIACIDE ET COMPOSITIONS ASSOCIÉES
Abstract: front page image
(EN)The present invention refers to a combination of hyaluronic acid, chondroitin sulfate in combination with at least one antacid agent, in particular magaldrate, for the prevention or treatment of gastric hyperacidity and gastroesophageal reflux and related pathologies thereof. More particularly, the combination is used for the preparation of oral compositions with at least one pharmaceutical carrier and advantageously that comprise a bioadhesive agent as well.
(FR)La présente invention concerne une association d'acide hyaluronique, du sulfate de chondroïtine en association avec au moins un agent antiacide, en particulier du magaldrate, pour la prévention ou le traitement de l'hyperacidité gastrique et du reflux gastro-œsophagien et de leurs pathologies associées. Plus particulièrement, ladite association est utilisée pour la préparation de compositions à administrer par voie orale comprenant au moins un vecteur de médicament et comprenant également avantageusement un agent bioadhésif.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: Italian (IT)